SEC Filings

Filing links are provided when reliable SEC filing data is available.

Recent Filings

Form	Filing Date	Accepted	Document
425	Sep 30, 2026	Sep 30, 2026	View filing
DEFA14A	Sep 30, 2026	Sep 30, 2026	View filing
SC 13G	Sep 24, 2026	Sep 24, 2026	View filing
4	Sep 22, 2026	Sep 22, 2026	View filing
4	Sep 22, 2026	Sep 22, 2026	View filing
4	Sep 22, 2026	Sep 22, 2026	View filing
4	Sep 22, 2026	Sep 22, 2026	View filing
4	Sep 22, 2026	Sep 22, 2026	View filing
4	Sep 10, 2026	Sep 10, 2026	View filing
4	Sep 10, 2026	Sep 10, 2026	View filing
4	Sep 10, 2026	Sep 10, 2026	View filing
DEFA14A	Sep 9, 2026	Sep 9, 2026	View filing
8-K	Sep 9, 2026	Sep 9, 2026	View filing
SC 13G/A	Sep 8, 2026	Sep 8, 2026	View filing
DEFM14A	Sep 4, 2026	Sep 4, 2026	View filing
10-Q	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
425	Aug 4, 2026	Aug 3, 2026	View filing
8-K	Aug 3, 2026	Aug 3, 2026	View filing
425	Jul 24, 2026	Jul 23, 2026	View filing
8-K	Jul 22, 2026	Jul 22, 2026	View filing
425	Jul 22, 2026	Jul 22, 2026	View filing
4	Jul 21, 2026	Jul 21, 2026	View filing
4	Jul 13, 2026	Jul 13, 2026	View filing
4	Jul 13, 2026	Jul 13, 2026	View filing
4	Jul 13, 2026	Jul 13, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing

About BioLife Solutions, Inc.

BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.

Bothell, WA

155 employees

www.biolifesolutions.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Roderick de Greef

View full financials